Abstract. Insulin infusion pump treatment (CSII) 
generally led to a reduction of 20\p=n-\37% of daily insulin dose but in 3 cases there was an increase of dose with the achievement of glycaemic control. A significant relation between bolus/basal ratio of insulin daily dose and the quality of glycaemic control was also found during CSII. All infants were born at or near to term and none were macrosomic or had neonatal complications. It is concluded that CSII is highly efficient in pregnancy not only in type I but also in type II or gestational diabetes.
In recent years several authors have employed open-loop infusion pumps and home glucose monitoring in small numbers of highly supervised non-pregnant patients, obtaining a striking im¬ provement in diabetic control (Pickup et al. 1978 (Pickup et al. , 1979 Champion et al. 1980; Mecklenburg et al. 1982) . The (Table. 2).
During pump treatment glucose control was significantly improved in the majority of patients. In patients with severe diabetes a significant re¬ duction of mean glucose concentration (P < 0.001), the standard deviation (P < 0.05) and the MAGE value (P < 0.05) was found during pump treatment (Fig. 1) 
